MLN Connects - May 19, 2022

Biosimilars: Safe, Effective, & May Reduce Patient Costs

MLN Connects newsletter for Thursday, May 19, 2022

News

  • Biosimilars: Safe, Effective, & May Reduce Patient Costs
  • PECOS Scroll Functionality
  • Clinical Laboratory Improvement Amendments: Unpaid Certificate Fees
  • Quarterly Update to the Medicare Physician Fee Schedule Database (MPFSDB)
  • Mental Health: Help Address Disparities

Compliance

  • Collaborative Patient Care is a Provider Partnership

MLN Matters® Articles

  • Elimination of Certificates of Medical Necessity & Durable Medical Equipment Information Forms
  • International Classification of Diseases, 10th Revision (ICD-10) and Other Coding Revisions to National Coverage Determination (NCDs)-October 2022 Update
  • Revisions to Medicare Part B Coverage of Pneumococcal Vaccinations for the Medicare Benefit Policy Manual Chapter 15, Section 50.4.4.2

Publications

  • Chronic Care Management Services - Revised
  • Home Health Quality Reporting Program: Draft OASIS-E Guidance Manual

 

Last Updated May 19 , 2022